Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H12N4O5 |
Molecular Weight | 244.2047 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
InChIKey=IWUCXVSUMQZMFG-AFCXAGJDSA-N
InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175466
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIBAVIRIN TEVA (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
WHO-ATC |
J05AP01
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
57491
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIBAVIRIN TEVA PHARMA B.V. (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
LIVERTOX |
NBK548115
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
WHO-VATC |
QJ05AB04
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
COTRONAK (REFUSED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/01/024
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.4.3
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
REBETOL (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
WHO-ATC |
J05AB04
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIBAVIRIN BIOPARTNERS (WITHDRAWN: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
162402
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RIBAVIRIN MYLAN (AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
163039
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
C807
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
3543
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
CHEMBL1643
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
100000089166
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
D012254
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
36791-04-5
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
1602706
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
SUB10297MIG
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
COPEGUS
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | APPROVED MARCH 2015 | ||
|
Ribavirin
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
m9593
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID8023557
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
63580
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
DB00811
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
6513
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
ribavirin
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
6842
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
66510-90-5
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
SUPERSEDED | |||
|
9344
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
RIBAVIRIN
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
49717AWG6K
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
2373
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
37542
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY | |||
|
49717AWG6K
Created by
admin on Fri Dec 15 15:35:07 UTC 2023 , Edited by admin on Fri Dec 15 15:35:07 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
PRODRUG (METABOLITE ACTIVE)